- View programme as: Grid view List view
- Print: Print
- Search
- Personal Planner
Sun 18 March
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Green Area, eURO Auditorium (Level 0)
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Green Area, eURO Auditorium (Level 0)
-
Plenary Session 3 - Prostate cancer
Prostate cancer Plenary Session 3
Prostate cancerPlenary Session 3Sunday 18 March08:00 - 10:30LocationGreen Area, eURO Auditorium (Level 0)Learning objectivesThis initial part of the session aims to illustrate the level and availability of genomic information needed to risk classify profile tumours according to their genetic profile. The audience will understand why efforts are made to develop genetic tests, and what is needed to make this a clinical tool.08:00 - 08:25Debate Genomic screening before active surveillance - Enough data?08:20 - 08:25Discussion08:25 - 08:40European Society for Medical Oncology (ESMO) lecture Metastatic castration-resistant prostate cancer (mCRPC)08:40 - 09:35Case-based debate Positron Emission Tomography–Computed Tomography (PET-CT) detected oligometastatic disease09:05 - 09:1509:25 - 09:35Discussion09:35 - 09:45Highlights from the poster sessions Androgen Receptor (AR) targeted therapy for non-metastatic Castration-Resistant Prostate Cancer (CRPC)09:45 - 10:30Case-based debate Locally advanced non-metastatic cancer in elderly patients10:20 - 10:30Discussion
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Green Area, eURO Auditorium (Level 0)
-
Green Area, Room 1 (Level 0)
-
Green Area, Room 2 (Level 0)
-
Red Area, Room 1 (Level 0)
-
Red Area, Room 2 (Level 0)
-
Red Area, Room 3 (Level 0)
-
Blue Area, Room 1 (Level 0)
-
Blue Area, Room 2 (Level 0)
-
Blue Area, Room 3 (Level 0)
-
Blue Area, Room 4 (Level 0)
-
Blue Area, Room 5 (Level 0)
-
Green Area, Room 15 (Level 0)
-
Green Area
-
Green Area, Room 10 (Level 1)
-
Green Area, Room 12 (Level 1)
-
Green Area, Room 11 (Level 1)
-
Orange Area, Room 1 (Level 0)
-
Orange Area, Room 2 (Level 0)
-
Orange Area, Room 3 (Level 0)
-
Orange Area, Room 4 (Level 0)
-
Orange Area, Room 5 (Level 0)
-
Orange Area, Room 6 (Level 0)
-
Orange Area, Room 7 (Level 0)
-
Yellow Area, Room 1 (Level 0)
-
Yellow Area, Room 2 (Level 0)
-
Yellow Area, Room 3 (Level 0)
-
Yellow Area, Room 4 (Level 0)
-
Yellow Area, Room 5 (Level 0)
-
Yellow Area, Iglo
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Green Area, eURO Auditorium (Level 0)
-
Consensus Highlight - EAU Consensus highlight and game changing session
EAU Consensus highlight and game changing session Consensus Highlight
EAU Consensus highlight and game changing sessionConsensus Highlight07:30 - 07:4507:45 - 07:55Game changer Prostate evaluation for clinically important disease: Sampling using image-guidance or not? (The PRECISION study, NCT02380027)07:55 - 08:00 -
Plenary session - Game changing session
Game changing session Plenary session
Game changing sessionPlenary session -
Plenary Session 3 - Prostate cancer
Prostate cancer Plenary Session 3
Prostate cancerPlenary Session 3Sunday 18 March08:00 - 10:30LocationGreen Area, eURO Auditorium (Level 0)Learning objectivesThis initial part of the session aims to illustrate the level and availability of genomic information needed to risk classify profile tumours according to their genetic profile. The audience will understand why efforts are made to develop genetic tests, and what is needed to make this a clinical tool.08:00 - 08:25Debate Genomic screening before active surveillance - Enough data?08:20 - 08:25Discussion08:25 - 08:40European Society for Medical Oncology (ESMO) lecture Metastatic castration-resistant prostate cancer (mCRPC)08:40 - 09:35Case-based debate Positron Emission Tomography–Computed Tomography (PET-CT) detected oligometastatic disease09:05 - 09:1509:25 - 09:35Discussion09:35 - 09:45Highlights from the poster sessions Androgen Receptor (AR) targeted therapy for non-metastatic Castration-Resistant Prostate Cancer (CRPC)09:45 - 10:30Case-based debate Locally advanced non-metastatic cancer in elderly patients10:20 - 10:30Discussion -
Plenary Session 5 - Precision medicine
Precision medicine Plenary Session 5
Precision medicinePlenary Session 508:00 - 08:30Case-based debate Is Prostate-Specific Membrane Antigen (PSMA)-Positron Emission Tomography–Computed Tomography (PET-CT) for Prostate-Specific Antigen (PSA) relapse worth the trouble?08:25 - 08:30Discussion08:30 - 08:45Urinary precision markers for the decision-making in prostate cancer08:45 - 09:10Case-based debate BRCA1/2 testing before treatment of metastatic Castration-Resistant Prostate Cancer (mCRPC)09:07 - 09:10Discussion09:10 - 09:25Société Internationale d’Urologie (SIU) lecture Now or never – Realising the promise of precision oncology for urothelial carcinoma09:25 - 10:15Case-based debate Invasive bladder cancer09:30 - 09:4010:00 - 10:15Discussion by panel10:15 - 10:25Game changer Results of POUT - A phase III randomised trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)10:25 - 10:30 -
Plenary Session 7 - Stones
Stones Plenary Session 7
StonesPlenary Session 7Tuesday 20 March08:00 - 13:30LocationGreen Area, eURO Auditorium (Level 0)Learning objectivesStones belong to the most common diseases, comparable with diabetes or hypertension. Management of urolithiasis is therefore daily business of most urologist. This plenary will cover important aspects and developments in pathogenesis, diagnosis, interventional treatment and prevention of urinary stones.08:00 - 08:2008:20 - 08:55Case-based debate How can we evaluate and treat the high-risk stone former?08:47 - 08:55Discussion08:55 - 09:10Urological Association of Asia (UAA) lecture Experience with 'mega stones' treatment09:10 - 09:35Debate Single-use flexible Ureteroscopy (URS): Ready to become standard?09:30 - 09:35Discussion09:35 - 10:20Case-based panel discussion Nightmares in ureteroscopy and percutaneous nephrolithotomy10:20 - 10:35Extracorporeal Shock Wave Lithotripsy (ESWL): The final knockout by Retrograde Intrarenal Surgery (RIRS)?10:35 - 11:00Debate Did patients benefit from miniaturisation of Percutaneous Nephrolithotomy (PNL)?10:55 - 11:00Discussion11:00 - 11:15What are the differences between the American Urological Association (AUA) and European Association of Urology (EAU) guidelines, and why?11:15 - 11:3011:30 - 13:30Souvenir Sessions By the EAU Scientific Committee -
Plenary Session 1 - Hot topics, evidence quality and advances in andrology
Hot topics, evidence quality and advances in andrology Plenary Session 1
Hot topics, evidence quality and advances in andrologyPlenary Session 1Saturday 17 March08:15 - 10:00LocationGreen Area, eURO Auditorium (Level 0)Learning objectivesIn recent years, deteriorating semen quality has been increasingly observed. Various researchers have identified changing lifestyle choices, such as delayed fatherhood and increased anabolic steroid abuse, but also increased exposure to environmental gonadotoxins as potential important causes of this phenomenon. In this plenary, an overview of these issues will be given, and the urologist will be updated on surgical options for the management of male infertility problems.
In the second half of the session, the focus will be on emerging therapies in andrology which are claimed to possess potential curative capacities such as low intensity shockwaves and cellular therapies. The quality of evidence supporting these novel therapies will be discussed in a case-based fashion.
08:15 - 08:30Are European men delaying fatherhood? Epidemiology and the effects of advancing paternal age on fertility potential and the offspring08:30 - 08:45Is the environment responsible for male infertility: What is the evidence?08:45 - 09:00EAU Guidelines snapshot presentation Surgical therapy for male infertility: Techniques and indications09:00 - 09:1509:15 - 09:45Case-based debate Low intensity Extracorporeal Shockwave Therapy (ESWT) for Erectile Dysfuntion (ED)09:40 - 09:45Discussion09:45 - 10:00American Urological Association (AUA) lecture Cellular therapies for andrology: Promising strategy or business opportunity? -
Meeting of the EAU Section of Uro-Technology (ESUT) in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS) - Technology Strikes Back
Technology Strikes Back Meeting of the EAU Section of Uro-Technology (ESUT) in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS)
Technology Strikes BackMeeting of the EAU Section of Uro-Technology (ESUT) in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS)Saturday 17 March10:30 - 17:50LocationGreen Area, eURO Auditorium (Level 0)Learning objectivesFollowing a more than 10-year tradition of live-surgery sessions, the EAU Section of Uro-Technology (ESUT) presents an ambitious programme focussing on novel techniques and technologies in endourological, laparoscopic and robotic-assisted procedures. This year, we want to focus on novel technology improving the performance of video-assisted surgery and diagnostics in all fields of Endourology. This session is conducted in collaboration with the the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS). In the laparoscopic and robot-assisted cases, we will focus on the developments of imaging as well as on new instruments and devices that improve its ergonomics. The latest digital developments for flexible endoscopy of the upper urinary tract for diagnosis and treatment of tumours and calculi will also be demonstrated.
ESUT faculty consists of internationally well-known experts serving as surgeons and moderators. The different surgical procedures will be transmitted from Herlev Hospital in Copenhagen in high definition and 3D quality. Traditionally, the format of ESUT Live Surgery will allow all delegates to directly communicate with the surgeons to ask questions and to discuss every aspect of the procedure. In addition, the ESUT session will also be available online.-Live broadcasts from Herlev Hospital, Copenhagen (DK)10:30 - 17:50Coordinators in the eURO Auditorium10:30 - 17:50Coordinator at Herlev Hospital, Copenhagen (DK)10:30 - 17:50Patient Advocates10:34 - 10:3910:39 - 12:24Live Surgery Part I12:24 - 14:13Live Surgery Part II12:24 - 12:3212:32 - 12:4012:48 - 12:5612:56 - 13:0413:47 - 14:02Supine Endoscopic Combined Intrarenal Surgery (ECIRS)14:13 - 15:51Live Surgery Part III15:51 - 17:45Live Surgery Part IV16:30 - 16:3816:38 - 16:4616:54 - 17:0217:02 - 17:1017:29 - 17:37 -
Specialty Session - Latest and hot news in medical treatment in onco-urology
Latest and hot news in medical treatment in onco-urology Specialty Session
Latest and hot news in medical treatment in onco-urologySpecialty Session10:30 - 12:00Conclusions from recent oncology meetings regarding: -
Video Session 09 - Technological solutions for BPH
Technological solutions for BPH Video Session 09
Technological solutions for BPHVideo Session 09V64Laser enucleation techniques in residual BPH managementBy: Enikeev D. , Glybochko P. , Alyaev Y. , Rapoport L. , Enikeev M. , Sorokin N. , Sukhanov R. , Taratkin M.Institutes: I.M. Sechenov First Moscow State Medcal University, Research Institute of Uronephrology and Reproductive Health, Moscow, RussiaV65Thulium fiber laser enucleation of the prostate in management of giant BPH (>200 cc)By: Enikeev D. , Glybochko P. , Alyaev Y. , Rapoport L. , Enikeev M. , Taratkin M.Institutes: I.M. Sechenov First Moscow State Medical University, Research Institute For Uronephrology And Reproductive Health, Moscow, RussiaV66Robot-assisted “pure” adenomectomy for large prostate adenoma: Is it the way to solve the bladder outlet obstruction and maintain a normal sexual function?By: Porpiglia F. , Fiori C. , Bertolo R. , Checcucci E. , Amparore D. , Scarpa R.M.Institutes: AOU San Luigi Gonzaga Orbassano – Turin; University of Turin, Dept. of Urology, Orbassano, ItalyV67Recommendations for safe and efficient morcellation after endoscopic enucleation of the prostate (EEP)By: Rijo E. 1 , Misrai V. 2 , Gomez-Sancha F. 3Institutes: 1Hospital Quiron Barcelona, Dept. of Urology, Barcelona, Spain, 2Clinique Pasteur, Dept. of Urology, Toulouse, France, 3ICUA-Clínica CEMTRO, Dept. of Urology, Madrid, SpainV68V69V63Transvesical robotic simple prostatectomy with 360° circumferential reconstruction: Step-by-step techniqueBy: Cacciamani G.E. 1 , Medina L. 1 , Ashrafi A.N 1 , Landsberger H. 1 , Winter M. 1 , Desai M. 1 , Aron M. 1 , Berger A. 2Institutes: 1University of Southern California, Dept. of Urology, Los Angeles, United States of America, 2USC Institute of Urology, Dept. of Urology, Los Angeles, United States of America -
Video Session 06 - Bladder cancer: Minimally invasive approaches
Bladder cancer: Minimally invasive approaches Video Session 06
Bladder cancer: Minimally invasive approachesVideo Session 06V41Robot-assisted laparoscopic en-bloc partial cystectomy, urachal resection, umbilectomy and pelvic lymphadenectomy with intracorporeal ultrasonography for urachal adenocarcinoma: A case reportBy: Proskura A. , Shpot E.Institutes: Sechenov University, Dept. of Urology, Moscow, RussiaV42V44V45Palliative cystectomy: Presentation of 3 casesBy: Medina Gonzalez A. , Perez Garcia C. , Gonzalez Rodriguez I. , Diaz Mendez B. , Cruceyra Betriu G. , Gil Ugarteburu R. , Fernandez-Pello Montes S. , Rúger Jiménez L. , Mosquera Madera J.Institutes: Hospital of Cabueñes, Dept. of UROLOGY, Gijón, SpainV46Endoscopic incision for uretero-ileal anastomotic stricture: Step by step techniqueBy: Pérez Schoch M. 1 , Carballo Quintá M. 1 , Almuster Domínguez S. 1 , Castro Iglesias M. 1 , Sánchez Ramos J. 1 , Montero Fabuena R. 1 , Díaz Álvarez J.M. 1 , Martínez Vázquez A. 2 , López García S. 1 , López Díez M.E. 1 , Martínez-Sapiña Llanas I. 1 , Barros Rodríguez J.M. 1 , Ojea Calvo A. 1Institutes: 1Hospital Álvaro Cunqueiro, Dept of Urology, Vigo, Spain, 2Hospital Álvaro Cunqueiro, Dept. of Radiology, Vigo, SpainV47V40Robot assisted totally intracorporeal Vescica Ileale Padovana (ra-VIP): A new technique for robotic bladder replacementBy: Cacciamani G.E. , De Marco V. , Sebben M. , Rizzetto R. , Cerruto M.A. , Porcaro A.B. , Artibani W.Institutes: AOUI, Azienda Ospedaliera Universitaria Integrata, Dept. of Urology, Verona, Italy -
Video Session 07 - Developments in endourology
Developments in endourology Video Session 07
Developments in endourologyVideo Session 07V48Feasibility of a single use disposable diagnostic digital cystoscope: Initial clinical experienceBy: Ostrowski A. 1 , Kowalski F. 2 , Banas M. 1 , Goli V. 3 , Denes B. 4 , Drewa T. 1Institutes: 1Nicolaus Copernicus University, Dept. of Oncological Urology, Bydgoszcz, Poland, 2Nicolaus Copernicus University, Dept of Oncological Urology, Bydgoszcz, Poland, 3Las Vegas Urology, Dept. of Urology, Las Vegas, United States of America, 4UroViu, Dept. of Clinical Development, Redwood City, United States of AmericaV49Green Light Laser for management of haemorrhergic cystitis – technique and initial resultsBy: Pascoe C. 1 , Christidis D. 2 , Manning T. 2 , Lamb B. 3 , Murphy D. 1 , Lawrentschuk N. 1Institutes: 1Peter MacCallum Cancer Center, Dept. of Cancer Surgery, Melbourne, Australia, 2Austin Health, Dept. of Surgery , Melbourne, Australia, 3Peter MacCallum Cancer Centre, Dept. of Cancer Surgery, Melbourne, AustraliaV50V51’’PiReS’’: How to build a bladder model for Pigtail Removal SimulationBy: Liakos N. , Henke C.A. , Franco P. , Wagner C. , Witt J.H.Institutes: St. Antonius Hospital Gronau, Dept. of Urology, Pediatric Urology and Urological Oncology, Prostate Center Northwest, Gronau, GermanyV52Surgical anatomy and changes in the morphology of the external urethral sphincter after endoscopic enucleation of the prostate measured by transrectal ultrasoundBy: Rijo E. 1 , Gil-Vernet J.M. 2Institutes: 1Hospital Quiron Barcelona, Dept. of Urology, Barcelona, Spain, 2Clínica Teknon Barcelona, Dept. of Urology, Barcelona, SpainV53V54“En bloc” thullium laser resection of NMIBC: Technique and preliminary resultsBy: Hurle R. , Saita A. , Lazzeri M. , Buffi N. , Lughezzani G. , Peschechera R. , Benetti A. , Pasini L. , Zandegiacomo S. , Lista G. , Cardone P. , Guazzoni G. , Casale P.Institutes: Istituto Clinico Humanitas IRCCS, Dept. of Urology, Rozzano, ItalyV55PDD-guided thulium fiber laser en-bloc enucleation of bladder tumorBy: Glybochko P. , Alyaev Y. , Rapoport L. , Enikeev D. , Enikeev M. , Sorokin N. , Sukhanov R. , Dymov A. , Taratkin M.Institutes: I.M. Sechenov First Moscow State Medcal University, Research Institute of Uronephrology and Reproductive Health, Moscow, Russia -
Video Session 10 - Innovative techniques for improving lymph node management
Innovative techniques for improving lymph node management Video Session 10
Innovative techniques for improving lymph node managementVideo Session 10V70Anatomical 3D image guidance for real-time lymph node localization during robot-assisted salvage lymphadenectomyBy: Önol F.F. , Palayapalayam Ganapathi H. , Rogers T. , Roof S. , Patel V.Institutes: Florida Hospital Global Robotics Institute, Dept. of Urology, Celebration, United States of AmericaV71Laparoscopic inguinal and pelvic lymphadenectomy in the penile cancer. A novel abdominal approachBy: Martinez Holguin E. , Subira Rios D. , Andres Boville G. , Jara Rascon J. , Moralejo Garate M. , Rodriguez Fernandez E. , Bueno Chomon G. , Hernandez Fernandez C.Institutes: Hospital General Universitario Gregorio Marañón, Dept. of Urology, Madrid, SpainV72Left post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND): Stage IIB seminomaBy: Baldissera Aradas J.V. , Miranda Aranzubia O. , Pérez Cadavid S. , Casas Agudo V. , Orosa Andrada A. , López León V. , Rivas Escudero J. , López Rellán E.Institutes: Bierzo hospital, Dept. of Urology, Ponferrada, SpainV73V74Surgical feasibility, and outcome of robot-assisted video endoscopic inguinal lymph node dissection in node positive groin of carcinoma penis patientsBy: Singh A. , Jaipuria J. , Baidya S. , Kumar R. , Jain J. , Rawal S.Institutes: Rajiv Gandhi Cancer Institute and Research Centre, Dept of Uro-Oncology, Delhi, IndiaV75Robot-assisted salvage lymph node dissection for nodal recurrence of prostate cancerBy: Brassetti A. , Proietti F. , Del Vecchio G. , Emiliozzi P. , Martini M. , Pansadoro A. , Scarpone P. , Pansadoro V.Institutes: Vincenzo Pansadoro Foundation, Dept. of Urology, Rome, ItalyV76Salvage robot-assisted retroperitoneal lymphadenectomy for prostate cancer nodal recurrence only detected by 68Ga-PSMA PET CT: Technical aspects and resultsBy: Mota Filho F.H.A. , Savio L.F. , Santos R. , Da Cruz J.A.S. , Passerotti C.C.Institutes: Hospital Alemão Oswaldo Cruz, Centro de Cirurgia Robótica, São Paulo, Brazil -
Video Session 08 - Emerging techniques in robotic renal surgery
Emerging techniques in robotic renal surgery Video Session 08
Emerging techniques in robotic renal surgeryVideo Session 08V56V57Robot-assisted nephrectomy and IVC thrombectomy in the treatment of renal cell carcinomaBy: Juárez Del Dago Anaya P. 1 , Gaston R. 2 , Cuadros Rivera V. 2 , Llanes González L. 2 , Reinoso J. 2 , Fernández Del Álamo J. 2 , Gomez Sancha F. 2Institutes: 1Gabinete de Urologia y Andrología, Dept. of Urology, Las Palmas de Gran Canaria, Spain, 2ICUA - Clinica CEMTRO, Dept. of Urology, Madrid, SpainV58ICG marked off-clamp robotic partial nephrectomy for endophytic renal tumors: Proof of concept and initial seriesBy: Simone G. 1 , Misuraca L. 1 , Tuderti G. 1 , Ferriero M. 1 , Minisola F. 1 , Vallati G. 2 , Pizzi G. 2 , Guaglianone S. 1 , Gallucci M. 1Institutes: 1Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy, 2Regina Elena National Cancer Institute, Dept. of Radiology, Rome, ItalyV59Robot-assisted partial nephrectomy with enucleative resection strategy for highly complex renal masses: Results from a high-volume referral cancer centreBy: Minervini A. , Campi R. , Mari A. , Sessa F. , Vanacore D. , Sforza S. , Tasso G. , Di Maida F. , Bencini G. , Morselli S. , Lapini A. , Carini M.Institutes: University of Florence, Dept. of Urology, Florence, ItalyV61V60V623D-modeling for vascular anatomy reconstruction before robotic partial nephrectomyBy: Schiavina R. 1 , Angiolini A. 1 , Borghesi M. 1 , Bianchi L. 1 , Chessa F. 1 , Vagnoni V. 1 , Mineo Bianchi F. 1 , Barbaresi U. 1 , Marcelli E. 2 , Bortolani B. 2 , Cercenelli L. 2 , Brunocilla E. 1Institutes: 1Sant'Orsola-Malpighi Hospital - University of Bologna, Dept. of Urology, Bologna, Italy, 2University of Bologna, Dept. of Bioengineering, Bologna, Italy -
Video Session 11 - Complex reconstructive genital surgery
Complex reconstructive genital surgery Video Session 11
Complex reconstructive genital surgeryVideo Session 11V77Gender confirmation vaginoplasty: The Chicago techniqueBy: Kocjancic E. 1 , Vigneswaran H. 1 , Sofer L. 1 , Jaunarena J. 1 , Whitehead D. 2 , Morgantini L.A. 1 , Schechter L. 2Institutes: 1University of Illinois at Chicago, Dept. of Urology, Chicago, United States of America, 2Weiss Memorial Hospital, Dept. of Plastic Surgery, Chicago, United States of AmericaV78A multi-center analysis on surgical technique, outcomes and learning curve of male-to-female penoscrotal vaginoplastyBy: Cocci A. 1 , Polloni G. 2 , Delle Rose A. 1 , Grisanti Caroassai S. 1 , Cito G. 1 , Serni S. 1 , Carini M. 1 , Matteucci V. 3 , Morelli G. 4Institutes: 1University of Florence, Dept. of urology, Florence, Italy, 2Psycho-Sexology, Dept. of Psycho-Sexology, Milan, Italy, 3Cisanello Hospital, Dept. of Surgery, Pisa, Italy, 4Cisanello Hospital, Dept. of urology, Pisa, ItalyV79Bladder exstrophy radial artery phalloplasty: Exstrophy related issues and saphenous vein interposition graftBy: Chiriacò G. , Blecher G. , Johnson M. , Sangster P. , Christopher N. , Ralph D.Institutes: University College London Hospitals (UCLH), Dept. of Andrology, London, United KingdomV80Surgical technique for complex cases of Peyronie’s disease: Penile prosthesis implantation, modified neurovascular bundle release and single or multiple corporeal incisions and grafting with collagen fleeceBy: Fernández-Pascual E. 1 , González-García J. 2 , Souto A.D. 1 , García E. 1 , Marcos D. 1 , Turo J. 1 , Carballido J. 1 , Martínez Salamanca J.I. 1Institutes: 1Puerta de Hierro Majadahonda University Hospital, Dept. of Urology, Madrid, Spain, 2Hospital Central de la Cruz Roja San José y Santa Adela, Dept. of Urology, Madrid, SpainV81Microsurgical vs robot-assisted vasovasostomy: Technical aspects and resultsBy: Umari P. 1 , De Naeyer G. 2 , Schatteman P. 2 , De Groote R. 2 , Fossati N. 3 , Gandaglia G. 3 , Heinze A. 2 , Rizzo M. 4 , Pavan N. 4 , Liguori G. 5 , Bucci S. 4 , Mottrie A. 2 , Trombetta C. 4Institutes: 1Ospedale Maggiore della Carità, Dept. of Urology, Novara, Italy, 2OLV Hospital Aalst, Dept. of Urology, Aalst, Belgium, 3Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 4Cattinara Hospital, Dept. of Urology, Trieste, Italy, 5Cattinara Hospital , Dept. of Urology, Trieste, ItalyV82New transscrotal approach for robotic microsurgical denervation of the spermatic cord with robotic microsurgical varicocelectomyBy: Gudeloglu A. 1 , Etafy M. 2 , Brahmbhatt J. 2 , Parekattil S. 3Institutes: 1Hacettepe University Medical Faculty, Dept. of Urology, Ankara, Turkey, 2PUR Clinic , Dept. of Urology, Clermont, United States of America, 3PUR Clinic, Dept. of Urology, Clermont, United States of AmericaV83Penile sclerosing granuloma - surgical excisionBy: Blecher G. 1 , Asher N. 2 , Chiriacò G. 1 , Ralph D.J. 1Institutes: 1University College of London Hospital, Dept. of Andrology, London, United Kingdom, 2University College of London Hospital, Dept. of Pathology, London, United KingdomV84Surgical management of severe post-operative skin necrosis after penile lengthening corporoplastyBy: Colombo F. , Gentile G. , Franceschelli A. , Vagnoni V. , Angiolini A. , Sadini P.Institutes: Andrology Unit - S. Orsola University Hospital, Dept. of Urology and Gynecology, Bologna, Italy -
Opening Ceremony - EAU Opening Ceremony
EAU Opening Ceremony Opening Ceremony
EAU Opening CeremonyOpening CeremonyFriday 16 March18:00 - 19:30LocationGreen Area, eURO Auditorium (Level 0)Welcome by Commissioner AndriukaitisAnnouncement of the new EAU Honorary MembersPresentation of the EAU Willy Gregoir Medal 2018Presentation of the EAU Frans Debruyne Life Time Achievement Award 2018Presentation of the EAU Crystal Matula Award 2018Presentation of the EAU Hans Marberger Award 2018EAU Ernest Desnos PrizePresentation of the EAU Prostate Cancer Research Award 2018
-
-
Green Area, Room 1 (Level 0)
-
Plenary Session 4 - Contemporary storage Lower Urinary Tract Symptoms (LUTS) management
Contemporary storage Lower Urinary Tract Symptoms (LUTS) management Plenary Session 4
Contemporary storage Lower Urinary Tract Symptoms (LUTS) managementPlenary Session 4Sunday 18 March08:00 - 10:15LocationGreen Area, Room 1 (Level 0)Learning objectivesThe aims and objectives of this session are to emphasise the fact that overactive bladder is a non-specific symptom complex and indeed "the bladder is an unreliable witness" and that there are a number of potential physiological causes for the symptom complex overactive bladder. Treatment options after failed conservative management and drug therapy will be discussed.
Continuing the theme of this session, lower urinary tract symptoms in the context of both stable and progressive neurogenic disease states and the important issue of age and the influence of polypharmacy when considering the management of OAB will be addressed.
A case presentation will focus on the dilemma concerning lower urinary tract symptoms associated with benign prostatic obstruction and the effect of surgery to relieve obstruction on these symptoms.
Take home message: The attendee at this session will understand the non-specific nature of urinary tract symptoms and appreciate current concepts on the appropriate investigation and management thereof including the potential effect of surgery for benign prostatic obstruction on associated lower urinary tract symptoms.08:00 - 08:15Pathophysiology of non neurogenic Overactive Bladder (OAB): Rather multifactorial than idiopathic disease08:15 - 08:55Debate Management of Overactive Bladder (OAB)/Urinary Incontinence (UI): What is the optimal strategy after failure of conservative treatment? Percutaneous Tibial Nerve Stimulation (PTNS)/Botox versus neuromodulation and other surgery08:15 - 08:35Team 1: Percutaneous Tibial Nerve Stimulation (PTNS)/Sacral Nerve Stimulation (SNS)08:35 - 08:55Team 2: Botox and surgery08:55 - 09:1009:10 - 09:2509:25 - 09:4009:40 - 10:15Case-based debate Management of storage LUTS before and after Benign Prostate Enlargement (BPE) surgery10:05 - 10:15Discussion -
Plenary Session 6 - Preventing urological disease: Future prospects
Preventing urological disease: Future prospects Plenary Session 6
Preventing urological disease: Future prospectsPlenary Session 6Monday 19 March08:00 - 10:30LocationGreen Area, Room 1 (Level 0)Learning objectivesDisease prevention is a topic of increasing importance throughout the medical field. Here the focus is on preventing urological diseases by addressing systemic disease processes: Preventing or slowing the progression of lower urinary tract symptoms, minimising invasive urological procedures in high-risk patients with multiple co-morbidities, and mitigating urological complications associated with other medical conditions. Practical specific care suggestions and solutions for improving lower urinary tract function in patients with other chronic medical conditions will be discussed.08:00 - 08:1508:15 - 08:25Prevention of infectious complications after prostate biopsy: A Cochrane analysis08:25 - 08:40Microbiota and Lower Urinary Tract Symptoms (LUTS): The new truth?08:40 - 08:55Prevention of morbidity and mortality in uroseptic patients08:55 - 09:1009:10 - 09:45Case-based debate Preventing LUTS by preventing/treating these diseases09:45 - 10:00Confederación Americana de Urología (CAU) lecture Modern treatment of LUTS10:00 - 10:15Late breaking news10:00 - 10:0810:15 - 10:30Society for Urologic Oncology (SUO) lecture Prevention of scientific mistakes and future science strategies for our patients -
Plenary Session 2 - Nightmare session: Bladder cancer management
Nightmare session: Bladder cancer management Plenary Session 2
Nightmare session: Bladder cancer managementPlenary Session 2Saturday 17 March08:15 - 10:00LocationGreen Area, Room 1 (Level 0)Learning objectivesThe European Association of Urology (EAU) Non-Muscle and/or Muscle Invasive Bladder Cancer (NMIBC) guidelines are meant to help minimise morbidity and improve the care of patients with Bladder Cancer (BC). However, there may be underuse of guideline-recommended care in this potentially curable cohort. One reason is that non-indexed patients are treated by urologists. The incidence of postoperative complications is still the most frequently used surrogate marker of quality in surgery. The EAU guidelines has advocated the use of Clavien-Dindo classification as a standardised approach to grade and report postoperative complications in urology. However, it does not apply for intraoperative complications, and there is a need for an additional tool. In the current session we will discuss three distinct difficult clinical situations coming from the daily practice of urology in BC care. We will discuss issues around these very challenging cases and propose actions to overcome these so-called "nightmare" cases for urologists.08:15 - 08:50Case-based debate pT0 post cystectomy - "You mean I went through all of this and there was no tumour"08:45 - 08:50Case solution08:50 - 09:25Case-based debate Complications after a lengthy, complex cystectomy09:20 - 09:25Case solution09:25 - 10:00Case-based debate Complications following an early re-resection after no muscle in first TURBT09:55 - 10:00Case solution -
Urology beyond Europe - Joint Session of the European Association of Urology (EAU) and the Arab Association of Urology (AAU)
Joint Session of the European Association of Urology (EAU) and the Arab Association of Urology (AAU) Urology beyond Europe
Joint Session of the European Association of Urology (EAU) and the Arab Association of Urology (AAU)Urology beyond EuropeFriday 16 March09:30 - 12:15LocationGreen Area, Room 1 (Level 0)Learning objectivesThis session aims to open a channel between European urology and the urologists in the Arab world. The chosen topics include future developments of robotic surgery, urinary stone treatment, andrology and reconstructive urology and European and Arab approaches to solve these problems. Thus all participants will be able to learn from alternatives.09:30 - 09:33Welcome and introduction09:33 - 10:13Robotic surgery in urology10:03 - 10:13Discussion10:13 - 10:53Urinary stones10:13 - 10:2810:43 - 10:53Discussion10:53 - 11:33Andrology11:08 - 11:2311:23 - 11:33Discussion11:33 - 12:13Reconstructive urology11:20 - 11:32Complications of continent cutaneous urinary diversion and how to avoidTo be confirmed11:33 - 11:4812:03 - 12:13Discussion12:13 - 12:15Closing remarks -
Meeting of the EAU Section of Urolithiasis (EULIS) - Management of stones: Advancing technology, increasing experience and changing concepts. Where are we in 2018?
Management of stones: Advancing technology, increasing experience and changing concepts. Where are we in 2018? Meeting of the EAU Section of Urolithiasis (EULIS)
Management of stones: Advancing technology, increasing experience and changing concepts. Where are we in 2018?Meeting of the EAU Section of Urolithiasis (EULIS)Saturday 17 March10:15 - 14:30LocationGreen Area, Room 1 (Level 0)Learning objectivesTechnological advancements, coupled with increasing experience have considerably changed our treatment concepts in the contemporary management of stone disease both in adults and children. Currently a very well-planned treatment and follow-up strategy including well-conducted “imaging studies” and “metabolic evaluation” are being considered as the crucial steps for a successful and complication-free outcomes. Moreover, a close follow-up for all cases (if possible on an individual basis particularly in “risk group “ patients) is certainly required to limit future stone recurrences and related complications which may well affect the life quality of stone forming cases. Thus, in this EULIS session, in addition to a close look at the recent developments in minimally invasive stone management particularly in “complex cases”; we will focus on the importance of “experience with tips and tricks” from the experts to increase stone-free rates and limit well known complications. Assessment of stone free status with appropriate timing and tools along with the essentials of follow-up period will be discussed in detail to outline some ongoing debates on these issues.10:20 - 11:00Metabolic evaluation and medical management of urinary stones10:20 - 10:3010:30 - 10:4010:40 - 10:5010:50 - 11:0011:00 - 11:50Video Session 1: Management of complex renal stones with Percutaneous Nephrolithotomy (PNL) – How I do it?11:00 - 11:1011:10 - 11:2011:40 - 11:50Discussion11:50 - 12:30Evaluation and follow-up of a stone former11:50 - 12:0012:10 - 12:2012:20 - 12:30Discussion12:30 - 13:10Complications can occur but how can I lower the risk? Tips and tricks from the experts12:30 - 12:4012:50 - 13:0013:00 - 13:10Discussion13:10 - 13:50Video Session 2: Management of complex renal stones with Flexible Ureterorenoscopy (FURS) – How I do it?13:10 - 13:2013:20 - 13:3013:30 - 13:4013:40 - 13:50Discussion13:50 - 14:20What's new in endourology for stones?13:50 - 14:0014:10 - 14:2014:20 - 14:30Closing remarks -
Thematic Session 10 - Management of complicated urinary stone disease
Management of complicated urinary stone disease Thematic Session 10
Management of complicated urinary stone diseaseThematic Session 10Monday 19 March10:30 - 12:00LocationGreen Area, Room 1 (Level 0)Learning objectivesTreating stones can be complex due to stone size or location, but as well due to specific comorbidities or anatomic anomalies. Choosing the best approach requires significant expertise and experience of the urologist. This session aims being a very interactive, practical discussion on selected cases to improve personal knowledge on difficult, complex situations.10:30 - 10:4010:40 - 11:15Case discussion A 2 cm lower pole stone in an obese patient is treated best...11:15 - 11:2511:25 - 12:00Case discussion Pus after puncture of an infectious staghorn stone11:30 - 11:40 -
Thematic Session 01 - Underactive bladder: Under-diagnosed and under-recognised
Underactive bladder: Under-diagnosed and under-recognised Thematic Session 01
Underactive bladder: Under-diagnosed and under-recognisedThematic Session 01Sunday 18 March10:30 - 12:00LocationGreen Area, Room 1 (Level 0)Learning objectivesThe session aims to discuss the pitfalls and advantages of current definitions in terms of research and management of Underactive Bladder (UAB). UAB broadly defines a symptom complex of bladder emptying problems and does not indicate a specific pathology. Pathophysiological mechanisms underlying UAB will be discussed. Treatment of underactive bladder will be reviewed on case studies with pro and con positions: TURP in male with BPO and detrusor hypocontractility, and the case of SNS in a young female with dysfunctional voiding and defecation problems.
10:30 - 10:4510:45 - 11:00What pathophysiological mechanisms is basic science unrevealing in underactive bladder?11:00 - 12:00Case discussion Treatment based on case studies11:00 - 11:0511:25 - 11:30Discussion11:30 - 11:3511:55 - 12:00Discussion -
Poster Session 63 - Straight access to the stone: Percutaneous nephrolithotomy
Straight access to the stone: Percutaneous nephrolithotomy Poster Session 63
Straight access to the stone: Percutaneous nephrolithotomyPoster Session 63Monday 19 March12:15 - 13:45To be confirmed855Is PCNL changing in the UK – analysis of 9500 cases from the BAUS PCNL RegistryBy: Finch W. 1 , Armitage J. 2 , Withington J. 3 , Irving S. 1 , Fowler S. 4 , Burgess N. 1 , Wiseman O. 2Institutes: 1Norfolk and Norwich University Hospitals, Dept. of Urology, Norwich, United Kingdom, 2Addenbrookes Hospital, Dept. of Urology, Cambridge, United Kingdom, 3Guy's Hospital, Dept. of Urology, London, United Kingdom, 4BAUS, Audit, London, United Kingdom856Nephrolithometry scoring systems in percutaneous nephrolithotomy: The Guy’s stone score, S.T.O.N.E. nephrolithometry, CROES nomogram and S-ReSC scoreBy: Bibi M. , Sellami A. , Ouanes Y. , Chaker K. , Ben Rhouma S. , Nouira Y.Institutes: Hospital La Rabta, Dept. of Urology, Tunis, Tunisia857Do culture positive residual fragments have an impact on postoperative SIRS in patients undergoing PNL?By: Degirmenci T. 1 , Bozkurt I.H. 1 , Çelik S. 1 , Arslan B. 2 , Yonguc T. 1 , Sefik E. 1 , Dincel C. 1Institutes: 1Bozyaka Education and Research Hospital, Dept. of Urology, Izmir, Turkey, 2Istanbul Taksim Training and Research Hospital, Dept. of Urology, Izmir, Turkey858859860861Assessing irrigation flows influence on clearance of renal calculi fragments during PCNL: A hydrodynamic computerized and practical model studyBy: Dekalo S. 1 , Barghouty Y. 1 , Shlain S. 2 , Liberzon A. 3 , Paster A. 3 , Aviram G. 4 , Sofer M. 1Institutes: 1Tel-Aviv Sourasky Medical Center, Dept. of Urology, Tel-Aviv, Israel, 2School of Mechanical Engineering, Dept. of Hydrology, Tel-Aviv, Israel, 3Tel-Aviv University , Dept. of Hydrology, Tel-Aviv, Israel, 4Tel-Aviv Sourasky Medical Center, Dept. of Radiology, Tel-Aviv, Israel862The effect of anterior calyx stone on complication and stone free rates in percutaneous nephrolithotomy operationsBy: Kalkanli A. 1 , Ozdemir E. 1 , Cilesiz N.C. 1 , Ozkan A. 1 , Arslan B. 1 , Hazar A.I. 1 , Aydin M. 1 , Tandogdu Z. 2Institutes: 1Taksim Gaziosmanpasa Training and Research Hospital, Dept. of Urology, Istanbul, Turkey, 2Northern Institute for Cancer Research Newcastle University, Dept. of Urology, Newcastle, United KingdomV87Associated video presentation Making the access to the upper calyx in supine position safer: ultrasound and minipercBy: Cepeda Delgado M. 1 , Poza M. 1 , Tapia A.M. 1 , García A. 1 , Miralles S. 2 , Mainez J.A. 1 , Alonso D.M. 1 , Amón J.H. 1Institutes: 1Río Hortega University Hospital, Dept. of Urology, Valladolid, Spain, 2Rio Hortega University Hospital, Dept. of Urology, Valladoid, Spain863864Mini-PCNL versus standard-PCNL for the management of 20-40 mm size kidney stones: The initial result of a multi-center randomized controlled trialBy: Zeng G.Institutes: Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, Dept. of Urology, Guangzhou, China865Comparison of Super-mini PCNL (SMP) versus Miniperc for stones larger than 2 cm: A propensity score-matching studyBy: Zeng G. 1 , Liu Y. 2 , Zhu W. 3Institutes: 1The First Affiliated Hospital of Guangzhou Medical University, Dept. of Urology, Guangzhou, China, 2The First Affiliated Hospital of Guangzhou Medical University, Minimally Invasive Surgery Center,Guangdong Key Laboratory of Urology, Dept. of Urology, Guangzhou, China, 3The First Affiliated Hospital of Guangzhou Medical University, Minimally Invasive Surgery Center,Guangdong Key Laboratory of Urology, Guangzhou, China866867Are the different renal drainage options after percutaneous nephrolithotomy different in terms of efficacy and safety? Percutaneous nephrostomy and ureteral stentsBy: Pimentel Torres J. , Oliveira J.N. , Mota P. , Cordeiro A. , Morais N. , Anacleto S. , Lima E.Institutes: Hospital de Braga, Dept. of Urology, Braga, Portugal -
Poster Session 33 - Better understanding LUTS: A look behind the curtain
Better understanding LUTS: A look behind the curtain Poster Session 33
Better understanding LUTS: A look behind the curtainPoster Session 33439Detrusor underactivity (DU) caused by bladder outlet obstruction (BOO) is associated with an early impairment of the bladder sensory mechanismBy: Vale L. 1 , Antunes-Lopes T. 1 , Avelino A. 1 , Birder L.A. 2 , Charrua A. 1 , Cruz F. 1Institutes: 1Hospital Sao João & Faculty of Medicine/i3S of Porto, Dept. of Urology, Porto, Portugal, 2University of Pittsburgh, Dept. of Pharmacology, Pittsburgh, United States of America440Overexpression of transient receptor potential vanilloid-4 (TRPV4) in urothelium of rat urinary bladder following bladder outlet obstructionBy: Cho Y.H. , Yu S.H. , Jeong S.H. , Park T.J. , Kim M.S. , Chung H.S. , Oh K.J. , Kim S-O. , Hwang E.C. , Jung S.I. , Kang T.W. , Park K. , Kwon D.D.Institutes: Chonnam National University Hospital, Dept. of Urology, Gwangju, Korea, South441MicroRNAs, inhibited by TNF-α, might influence smooth muscle remodeling during outlet obstruction-induced lower urinary tract dysfunctionBy: Hashemi Gheinani A. 1 , Koeck I. 1 , Burkhard F. 2 , Monastyrskaya K. 1Institutes: 1University of Bern, Dept. of BioMedical Research, Bern, Switzerland, 2University Hospital, Dept. of Urology, Bern, Switzerland442Enhanced urinary extracellular vesicle isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discoveryBy: Hashemi Gheinani A. 1 , Vögeli M. 1 , Baumgartner U. 2 , Vassella E. 3 , Draeger A. 4 , Burkhard F. 5 , Monastyrskaya K. 1Institutes: 1University of Bern, Dept. of BioMedical Research, Bern, Switzerland, 2University of Bern, Dept. of Urology, Bern, Switzerland, 3University of Bern, Dept. of Pathology, Bern, Switzerland, 4University of Bern, Dept. of Anatomy, Bern, Switzerland, 5University Hospital , Dept. of Urology, Bern, Switzerland443444RQ-00434739, a novel TRPM8 antagonist, inhibits prostaglandin-E2-induced hyperactivity of the primary bladder afferent nerves in ratsBy: Aizawa N. 1 , Ohshiro H. 2 , Watanabe S. 2 , Homma Y. 3 , Igawa Y. 1Institutes: 1The University of Tokyo Graduate School of Medicine, Dept. of Continence Medicine, Tokyo, Japan, 2RaQualia Pharma Inc., Discovery Research, Nagoya, Japan, 3Japanese Red Cross Medical Center, Director, Tokyo, Japan445Supraspinal lower urinary tract control in spinal cord injury patients undergoing intradetrusor onabotulinumtoxinA injections: An MRI studyBy: Leitner L. 1 , Walter M. 1 , Liechti M. 1 , Michels L. 2 , Kollias S. 2 , Mehnert U. 1 , Kessler T. 1Institutes: 1Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital, Dept. of Neuro-Urology, Zürich, Switzerland, 2University of Zürich, University Hospital Zürich, Institute of Neuro-Radiology, Zürich, Switzerland446A three-dimensional scaffold containing encapsulated adipose-derived stem cells promotes bladder reconstruction via SDF-1α/CXCR4 pathwayBy: Xiao D. 1 , Yan H. 1 , Zhang M. 1 , Lv X. 1 , Li W. 2 , Lu M. 1Institutes: 1Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Dept. of Urology and Andrology, Shanghai, China, 2RenjiHospital Shanghai Jiao Tong University School Of Medicine, The State Key Lab of Metal Matrix Composites, Shanghai, China447448fMRI in patients with detrusor sphincter dyssynergia - is the neural circuit affected?By: Seseke S. 1 , Dechent P. 2 , Trojan L. 3Institutes: 1Martha-Maria-Hospital Halle-Dölau, Dept. of Urology, Halle, Germany, 2Georg-August-University, Dept. of Cognitive Neurology, Göttingen, Germany, 3Georg-August-University, Dept. of Urology, Göttingen, Germany449Inhibition of prostate smooth muscle contraction by inhibitors of polo-like kinases (PLK): A new role for PLK1 in smooth muscle contraction?By: Hennenberg M. , Kuppermann P. , Yu Q. , Rutz B. , Wang Y. , Herlemann A. , Strittmatter F. , Stief C. , Gratzke C.Institutes: University of Munich, Dept. of Urology, Munich, Germany450451Whole-transcriptome analysis in bladder pain syndrome/interstitial cystitis by next-generation sequencing: A distinct genomic landscape by the phenotypesBy: Akiyama Y. , Niimi A. , Nomiya A. , Fujimura T. , Fukuhara H. , Kume H. , Igawa Y. , Homma Y.Institutes: Graduate School of Medicine, The University of Tokyo, Dept. of Urology, Tokyo, Japan452Epigenetic regulation of COX-2 expression by DNA methylation via NF-κB activation in ketamine-induced ulcerative cystitisBy: Juan Y-S. 1 , Chuang S-M. 2 , Wen-Jeng W. 1 , Chen-Yu L. 3 , Yi-Lun L. 4 , Chuang S-M. 2 , Weng-Chen W. 1Institutes: 1Kaohsiung Municipal Ta-Tung Hospital, Dept. of Urology, Kaohsiung, Taiwan, 2Kaohsiung Medical University, Dept. of Urology, Kaohsiung, Taiwan, 3Kaohsiung Medical University, Dept. of Gynecology, Kaohsiung, Taiwan, 4Sinying Hospital, Dept. of Urology, Tainan, Taiwan453A mussel protein-based underwater tissue adhesive sealant: Pre-clinical animal study for vesico-vaginal fistulaBy: Pyun J.H. 1 , Kim H.J. 2 , Shim J.S. 3 , Kang S.G. 3 , Joo K.J. 1 , Cheon J. 3 , Cha H.J. 2 , Kang S.H. 3Institutes: 1Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Dept. of Urology, Seoul, Korea, South, 2Pohang University of Science and Technology (POSTECH), Chemical Engineering, Seoul, Korea, South, 3Korea University College of Medicine, Dept. of Urology, Seoul, Korea, South -
Specialty Session - Common problems in bladder cancer; evidence based debates
Common problems in bladder cancer; evidence based debates Specialty Session
Common problems in bladder cancer; evidence based debatesSpecialty SessionFriday 16 March12:30 - 15:30LocationGreen Area, Room 1 (Level 0)Learning objectivesAfter completion of this activity, participants will be able to:
• Discuss complex clinical changes in treating patients with bladder cancer.
• Discuss treatment alternatives in different bladder cancer disease states.
• Discuss the rationale for selecting particular therapy when a variety of treatment options exist.
• Discuss the clinical implications of biomarkers for diagnosis and prognosis.
12:30 - 12:3312:33 - 12:55Case-based Debate: Does variant histology change management of non-invasive bladder cancer?12:35 - 12:45Discussants12:48 - 12:55Questions and answers12:55 - 13:17Case-based Debate: My patient has a normal cystoscopy but a positive urine marker: What now?12:57 - 13:07Discussants13:10 - 13:17Questions and answers13:17 - 13:39Case-based Debate: Recurrent TaLG bladder tumours, failed BCG, Mitomycin: What are the options?13:19 - 13:29Discussants13:32 - 13:39Questions and answers13:39 - 14:01Case-based Debate: How should I treat a patient with initial T1HG disease and no tumour on re-TUR?13:41 - 13:51Discussants13:54 - 14:01Question and answers14:01 - 14:23Case-based Debate: What to do now that my patient’s tumour has been molecularly classified (and does it matter!)?14:03 - 14:13Discussants14:16 - 14:23Questions and answers14:23 - 14:45Case-based Debate: How should I manage a patient with tumour recurrence despite adequate BCG?14:25 - 14:35Discussants14:38 - 14:45Questions and answers14:45 - 15:07Case-based Debate: How to treat multi-focal Ta, HG disease if BCG is unavailable?14:47 - 14:57Discussants15:00 - 15:07Questions and answers15:07 - 15:29Case-based Debate: Marker-driven use of NAC in (T2) urothelial cancer in an otherwise healthy patient?15:09 - 15:19Discussants15:22 - 15:29Questions and answers15:29 - 15:30Closing remarks -
Poster Session 73 - Safe access through natural orifice: It is the era of ureteroscopy
Safe access through natural orifice: It is the era of ureteroscopy Poster Session 73
Safe access through natural orifice: It is the era of ureteroscopyPoster Session 73Monday 19 March14:00 - 15:30To be confirmed990Double-blinded prospective randomized clinical trial comparing regular and moses modes of holmium laser lithotripsy: Preliminary resultsBy: Ibrahim A. , Fahmy N. , Carrier S. , Elhilali M. , Andonian S.Institutes: McGill University Health Centre, Dept. of Urology, Montreal, Canada991The comparative clinical study of Ho: YAG and SuperPulse Tm fiber laser lithotriptersBy: Ergakov D. 1 , Martov A.G. 1 , Guseynov M. 1 , Traxer O. 2Institutes: 1Moscow City D.D. Pletnew's Hospital, Dept. of Urology, Moscow, Russia, 2Université Pierre et Marie Curie, Paris, FranceV06Understanding non-contact laser lithotripsy for dusting – the popcorn effect: A video analysisBy: Aldoukhi A. 1 , Roberts W. 1 , Hall T. 2 , Ghani K. 1Institutes: 1University of Michigan, Dept. of Urology, Ann Arbor, United States of America, 2University of Michigan, Dept. of Biomedical Engineering, Ann Arbor, United States of America992993Spinal versus general anesthesia for retrograde intrarenal surgery: A prospective double-blinded randomized-controlled trialBy: Mohamed M.H.A.T. 1 , Al-Hamri S. 2 , Askar A. 2 , Al-Rawagadh M. 3Institutes: 1Cairo University, Dept. of Urology, Cairo, Egypt, 2National Guard Hospital, Dept. of Urology, Riyadh, Saudi Arabia, 3AL-Moosa Specialized Hospital, Dept. of Urology, Alahsa, Saudi Arabia994Comparison of eight digital (reusable and disposable) flexible ureteroscopes deflection properties: In-vitro study in 10 different scope settingsBy: Dragos L.B. 1 , Rodriguez-Monsalve Herrero M. 2 , Somani B.K. 3 , Keller E.X. 2 , De Coninck V. 2 , Martis S.M. 4 , Bres-Niewada E. 5 , Sener T.E. 6 , Buttice S. 7 , Daminescu L.C. 4 , Pupca G.N. 1 , Bardan R.T. 1 , Cumpanas A.A. 1 , Iacoboaie C. 2 , Doizi S. 2 , Traxer O. 8Institutes: 1University of Medicine and Pharmacy, Dept. of Urology, Timisoara, Romania, 2Tenon Hospital, Dept. of Urology, Paris, France, 3University Hospital Southampton NHS Trust, Dept. of Urology, Southampton, United Kingdom, 4Emergency Clinical County Hospital, Dept. of Urology, Timisoara, Romania, 5Medical University of Warsaw, Dept. of Urology, Warsaw, Poland, 6Marmara University, Dept. of Urology, Istanbul, Turkey, 7San Giovanni di Dio Hospital, Dept. of Urology, Agrigento, Italy, 8Tenon Hospital, Sorbonne Universités, UPMC Paris VI, Groupe de Recherche Clinique sur la Lithiase Urinaire, GRC nº20, Dept. of Urology, Paris, France995Single-use versus reusable ureteroscopes for retrograde intrarenal surgery (RIRS): Systematic comparative analysis of physical and optical properties in three different devicesBy: Deininger S. , Haberstock L. , Todenhoefer T. , Neumann E. , Bedke J. , Stenzl A. , Kruck S. , Rausch S.Institutes: Eberhard-Karls-University Tuebingen, Dept. of Urology, Tübingen, Germany996997Comparison of intrarenal pelvic pressure levels during flexible ureteroscopy, mini-percutaneous nephrolithotomy and conventional percutaneous nephrolithotomy in a kidney modelBy: Doizi S. , Uzan A. , Keller E. , De Coninck V. , Rodriguez-Monsalve Herrero M. , Traxer O.Institutes: Tenon Hospital, Assistance-Publique Hôpitaux de Paris. Pierre et Marie Curie University., Dept. of Urology, Paris, France998Comparison of stone free rates and quality of life between percutaneous nephrolithotomy (PNL) and retrograde intra-renal surgery (RIRS) in management of 2-4 cm renal stones: A prospective controlled studyBy: Üçer O. , Erbatu O. , Albaz A.C. , Temeltaş G. , Gümüş B. , Müezzinoğlu T.Institutes: Manisa Celal Bayar University, Faculty of Medicine, Dept. of Urology, Manisa, Turkey999Head to head comparison of flexible ureterorenoscopy (fURS) versus robot-assisted flexible URS (rfURS) using the Avicenna Roboflex URS robotBy: Klein J-T. 1 , Charalampogianis N. 2 , Fiedler M. 2 , Kabakci S. 3 , Tokatli Z. 4 , Rassweiler J. 2Institutes: 1University Hospital, Dept. of Urology and Pediatric Urology, Ulm, Germany, 2SLK-Kliniken GmbH, Dept. of Urology , Heilbronn, Germany, 3University Ankara, Dept. of Bioengineering, Ankara, Turkey, 4Medicana International Ankara, Dept. of Urology, Ankara, Turkey1000Reducing operative complications from kidney stones (ROCKS): Understanding emergency department visits after ureteroscopy in a statewide collaborativeBy: Ghani K. 1 , Kim T. 1 , Telang J. 1 , Johnson A. 1 , Roberts W. 1 , Tekchandani A. 2 , Wynberg J. 3 , Leese J. 4 , Kadlec A. 5 , Dauw C. 1 , Hollingsworth J.M. 1Institutes: 1University of Michigan, Dept. of Urology, Ann Arbor, United States of America, 2MidMichigan Health, Dept. of Urology, Midland, United States of America, 3Detroit Medical Center, Dept. of Urology, Detroit, United States of America, 4IHA Urology, Dept. of Urology, Ann Arbor, United States of America, 5West Michigan Urological Associates, Dept. of Urology, Holland, United States of America1001Ureterorenoscopy with double JJ stent and its impact on sexual function in young men: A prospective randomised multicenter controlled studyBy: Khouni H. 1 , Boulma R. 1 , Raboudi M. 1 , Khiari R. 2 , Ghozzi S. 2 , Ben Rais N. 2Institutes: 1Internal Forces security Hospital, Dept. of Urology, La Marsa, Tunisia, 2Military Hospital, Dept. of Urology, Tunis, Tunisia -
Poster Session 43 - Whats new from the bench: Treating or preventing LUTS
Whats new from the bench: Treating or preventing LUTS Poster Session 43
Whats new from the bench: Treating or preventing LUTSPoster Session 43Sunday 18 March14:00 - 15:30578Which mechanism account for chronic bladder pain that develops later in life in individuals who suffer stressful events during infancy and adolescence?By: Matos R. 1 , Serrão P. 2 , Cruz F. 3 , Charrua A. 1Institutes: 1Faculty of Medicine of University of Porto, Dept. of Biomedical Science, Porto, Portugal, 2University of Porto, Dept. of Biomedical Science, Porto, Portugal, 3University of Porto, Dept. of Urology, Porto, Portugal579Anti-Nogo-A antibodies: A causal treatment for neurogenic lower urinary tract dysfunction due to spinal cord injury?By: Schneider M.P. 1 , Sartori A. 1 , Ineichen B. 1 , Schwab M. 2 , Kessler T. 1Institutes: 1University of Zürich, Balgrist University Hospital, Spinal Cord Injury Center & Research, Dept. of Neuro-Urology, Zürich, Switzerland, 2Brain Research Institute, University of Zürich, Dept. of Health Sciences and Technology, Zürich, Switzerland580Prevention of neurogenic detrusor overactivity following spinal cord injury: Effects of early administration of resiniferatoxin and botulinum toxin ABy: Oliveira R. 1 , Sousa Chambel S. 1 , Silva R. 1 , Coelho A. 1 , Cruz F. 2 , Duarte Cruz C. 1Institutes: 1Faculty of Medicine, University of Porto, Dept. of Biomedicine, Porto, Portugal, 2Hospital São João, Dept. of Urology, Porto, Portugal581ESWT protects from bladder dysfunction after traumatic spinal cord injury via a toll-like receptor 3 dependent mechanismBy: Nägele F. 1 , An A. 1 , Graber M. 1 , Lobenwein D. 2 , Kremser C. 3 , Hirsch J. 1 , Pölzl L. 1 , Grimm M. 1 , Holfeld J. 1 , Tepeköylü C. 1Institutes: 1Innsbruck Medical University, University Hospital for Cardiac Surgery, Innsbruck, Austria, 2Innsbruck Medical University, Dept. of Clinical and Functional Anatomy, Dept. of Anatomy, Histology and Embryology, Innsbruck, Austria, 3Innsbruck Medical University, Dept. of Radiology, Innsbruck, Austria582Can antioxidant therapy be protective against diabetes-induced bladder dysfunction?By: Tsounapi P. 1 , Honda M. 1 , Shimizu R. 1 , Nishikawa R. 1 , Teraoka S. 1 , Kimura Y. 1 , Yumioka T. 1 , Yamaguchi N. 1 , Iwamoto H. 1 , Morizane S. 1 , Dimitriadis F. 2 , Hikita K. 1 , Sofikitis N. 3 , Takenaka A. 1Institutes: 1Tottori University Faculty of Medicine, Dept. of Urology, Yonago, Japan, 2Aristotle University of Thessaloniki School of Medicine, Dept. of Urology, Thessaloniki, Greece, 3University of Ioannina, School of Medicine, Dept. of Urology, Ioannina, Greece583The finasteride can promote kidney changes? A study developed in a model of benign prostatic hyperplasiaBy: Da Silva M. , Estrada J. , Sampaio F.
-